COCP
Cocrystal Pharma Inc
NASDAQ: COCP · HEALTHCARE · BIOTECHNOLOGY
$1.39
+0.00% today
Updated 2026-04-29
Market cap
$19.71M
P/E ratio
—
P/S ratio
92.45x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$1 – $2
Volume
3.0M
Cocrystal Pharma Inc (COCP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-111.40%
ROA
-48.70%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2007 | — | $-58723.00 | — | — | — |
| 2008 | — | $-52917.00 | — | — | — |
| 2009 | — | $-41370.00 | — | — | — |
| 2010 | — | $-48478.00 | — | — | — |
| 2011 | $12.61M | $-5.46M | 31.46% | -30.84% | -43.29% |
| 2012 | $17.19M | $-7.96M | 42.01% | -15.34% | -46.33% |
| 2013 | — | $-19.62M | — | — | — |
| 2014 | $9000.00 | $-99000.00 | 54.77% | -64,433.33% | -1,100.00% |
| 2015 | $78000.00 | $-50.12M | -146.15% | -69,164.10% | -64,258.97% |
| 2016 | $0.00 | $-74.87M | — | — | — |
| 2017 | $0.00 | $-613000.00 | — | — | — |
| 2018 | $0.00 | $-49.05M | — | — | — |
| 2019 | $6.56M | $-48.17M | 39.00% | -737.45% | -733.84% |
| 2020 | $2.01M | $-9.65M | -199.60% | -475.97% | -479.05% |
| 2021 | $5.43M | $-14.19M | -162.04% | -262.04% | -261.38% |
| 2022 | $0.00 | $-38.84M | — | — | — |
| 2023 | $0.00 | $-17.98M | — | — | — |
| 2024 | $0.00 | $-17.50M | — | — | — |
| 2025 | $0.00 | $-8.83M | — | — | — |